ZEO ScientifiX Inc OCEL

Primary Symbol: ZEOX

Healthcare Drug Manufacturers - Major

Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company. It develops biological therapeutics for the treatment of degenerative diseases and regenerative medicine. Its products are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent and an autologous non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood (RAAM Products). Its RAAM Products and related services are principally used in the health care industry, administered by doctors and clinics. The Company’s product, Zofin (Organicell Flow), is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs. Patient Pure X, its autologous product, is a non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood.

OTCQB:ZEOX - Post by User

ZEO ScientifiX Inc

<< Previous

Bullboard Posts

Next >>

Post by indaknownewfieon May 12, 2021 12:09pm

111 Views

Post# 33183116

Organicell In Pakistan for Compassionate use

Zofin approved as well as an additional 60 subject suffering from moderate to Severe covid . Results due at end of June from the second cohort study of 65 persons using Zofn for COVID in India Wondering about their COPD and Osteoarthritis indications as well as their FDA results and partnership with the CDC

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security